Bridge TO Life
Provider of organ preservation solutions, disposables and machine perfusion systems focused on hypothermic oxygenated perfusion. Operates clinical trials and collaborates with transplant centers and organ procurement organizations to develop and validate preservation protocols and devices, and maintains global distribution and quality system certifications. Offers sterile saline products and standardized protocols for preparation and aseptic use of slushed cooling media for organ recovery, storage and transport.
Industries
Nr. of Employees
small (1-50)
Bridge TO Life
US Corporate Headquarters: 707 Skokie Blvd. Suite 340, Northbrook, IL 60062, USA; Logistics & Ordering: 3300 Breckinridge Blvd. Suite 200, Duluth, GA 30096, USA
Patents
Products
Belzer UW cold storage solution
A cold storage organ preservation solution with a defined composition for static cold storage of organs prior to transplantation.
Belzer MPS machine perfusion solution
A solution formulated for use as a perfusate in machine perfusion procedures for organ preservation.
EasiSlush sodium chloride solution for slush preparation
Sterile 0.9% sodium chloride solution supplied in single-use bags within double-barrier sterile packaging intended for preparation of slushed saline to provide topical organ hypothermia during recovery, storage and transport.
Hypothermic oxygenated machine perfusion system
A machine perfusion system engineered to support hypothermic oxygenated perfusion protocols with monitoring capabilities and data export for clinical use and research.
French-sized cannulas & tubing for organ perfusion
Color-coded, French-sized cannulas and tubing with suture bump features and kink-resistant connectors intended for organ perfusion procedures.
Belzer UW cold storage solution
A cold storage organ preservation solution with a defined composition for static cold storage of organs prior to transplantation.
Belzer MPS machine perfusion solution
A solution formulated for use as a perfusate in machine perfusion procedures for organ preservation.
EasiSlush sodium chloride solution for slush preparation
Sterile 0.9% sodium chloride solution supplied in single-use bags within double-barrier sterile packaging intended for preparation of slushed saline to provide topical organ hypothermia during recovery, storage and transport.
Hypothermic oxygenated machine perfusion system
A machine perfusion system engineered to support hypothermic oxygenated perfusion protocols with monitoring capabilities and data export for clinical use and research.
French-sized cannulas & tubing for organ perfusion
Color-coded, French-sized cannulas and tubing with suture bump features and kink-resistant connectors intended for organ perfusion procedures.
Services
Planning and execution support for multicenter clinical trials evaluating perfusion protocols and devices; collection and analysis of clinical endpoints and economic outcomes.
International distribution via local distributors and direct order processing for preservation solutions, disposables and perfusion systems.
Planning and execution support for multicenter clinical trials evaluating perfusion protocols and devices; collection and analysis of clinical endpoints and economic outcomes.
International distribution via local distributors and direct order processing for preservation solutions, disposables and perfusion systems.
Expertise Areas
- Organ preservation and perfusion
- Clinical trial management and multicenter randomized trials
- Medical device development and validation for transplantation
- Regulatory compliance and quality management (CE marking, ISO 13485, FDA interactions)
Key Technologies
- Hypothermic oxygenated perfusion
- Machine perfusion systems
- Static cold storage solutions
- Organ preservation solution formulation
News & Updates
Company announced certification to ISO 13485:2016 for quality management related to hypothermic oxygenated perfusion and cold flush organ preservation solutions.
Company announced FDA Investigational Device Exemption approval for its liver machine perfusion system to support enrollment in a U.S. pivotal clinical trial.
Company presented 12-month clinical trial results and additional analyses from a pivotal randomized trial of hypothermic oxygenated perfusion at international transplant congresses.
Company announced FDA 510(k) clearance for multi-sourced cold storage and machine perfusion preservation solutions with expanded labeling for machine perfusion solution across abdominal organs.
Company reported that more than 5,000 liver perfusions have been performed worldwide using hypothermic oxygenated perfusion in combination with its machine perfusion system.
Company announced certification to ISO 13485:2016 for quality management related to hypothermic oxygenated perfusion and cold flush organ preservation solutions.
Company announced FDA Investigational Device Exemption approval for its liver machine perfusion system to support enrollment in a U.S. pivotal clinical trial.
Company presented 12-month clinical trial results and additional analyses from a pivotal randomized trial of hypothermic oxygenated perfusion at international transplant congresses.
Company announced FDA 510(k) clearance for multi-sourced cold storage and machine perfusion preservation solutions with expanded labeling for machine perfusion solution across abdominal organs.
Company reported that more than 5,000 liver perfusions have been performed worldwide using hypothermic oxygenated perfusion in combination with its machine perfusion system.